Literature DB >> 21537011

A promising target for treatment of multidrug-resistant bacterial infections.

Martin S Davey, Jonathan M Tyrrell, Robin A Howe, Timothy R Walsh, Bernhard Moser, Mark A Toleman, Matthias Eberl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21537011      PMCID： PMC3122435          DOI： 10.1128/AAC.00382-11

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

Review 1.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

Authors:  Helen W Boucher; George H Talbot; John S Bradley; John E Edwards; David Gilbert; Louis B Rice; Michael Scheld; Brad Spellberg; John Bartlett
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

2.  Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs.

Authors:  H Jomaa; J Wiesner; S Sanderbrand; B Altincicek; C Weidemeyer; M Hintz; I Türbachova; M Eberl; J Zeidler; H K Lichtenthaler; D Soldati; E Beck
Journal:  Science       Date:  1999-09-03       Impact factor: 47.728

3.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.

Authors:  Karthikeyan K Kumarasamy; Mark A Toleman; Timothy R Walsh; Jay Bagaria; Fafhana Butt; Ravikumar Balakrishnan; Uma Chaudhary; Michel Doumith; Christian G Giske; Seema Irfan; Padma Krishnan; Anil V Kumar; Sunil Maharjan; Shazad Mushtaq; Tabassum Noorie; David L Paterson; Andrew Pearson; Claire Perry; Rachel Pike; Bhargavi Rao; Ujjwayini Ray; Jayanta B Sarma; Madhu Sharma; Elizabeth Sheridan; Mandayam A Thirunarayan; Jane Turton; Supriya Upadhyay; Marina Warner; William Welfare; David M Livermore; Neil Woodford
Journal:  Lancet Infect Dis       Date:  2010-08-10       Impact factor: 25.071

Review 4.  Microbial isoprenoid biosynthesis and human gammadelta T cell activation.

Authors:  Matthias Eberl; Martin Hintz; Armin Reichenberg; Ann-Kristin Kollas; Jochen Wiesner; Hassan Jomaa
Journal:  FEBS Lett       Date:  2003-06-05       Impact factor: 4.124

5.  Fosmidomycin for malaria.

Authors:  Michel A Missinou; Steffen Borrmann; Andreas Schindler; Saadou Issifou; Ayola A Adegnika; Pierre-Blaise Matsiegui; Ronald Binder; Bertrand Lell; Jochen Wiesner; Thomas Baranek; Hassan Jomaa; Peter G Kremsner
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

6.  Pharmacokinetics of fosmidomycin, a new phosphonic acid antibiotic.

Authors:  T Murakawa; H Sakamoto; S Fukada; T Konishi; M Nishida
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

7.  Human neutrophil clearance of bacterial pathogens triggers anti-microbial γδ T cell responses in early infection.

Authors:  Martin S Davey; Chan-Yu Lin; Gareth W Roberts; Sinéad Heuston; Amanda C Brown; James A Chess; Mark A Toleman; Cormac G M Gahan; Colin Hill; Tanya Parish; John D Williams; Simon J Davies; David W Johnson; Nicholas Topley; Bernhard Moser; Matthias Eberl
Journal:  PLoS Pathog       Date:  2011-05-12       Impact factor: 6.823
  7 in total
  13 in total

1.  Crystal structure of Brucella abortus deoxyxylulose-5-phosphate reductoisomerase-like (DRL) enzyme involved in isoprenoid biosynthesis.

Authors:  Jordi Pérez-Gil; Bárbara M Calisto; Christoph Behrendt; Thomas Kurz; Ignacio Fita; Manuel Rodríguez-Concepción
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

2.  Characterization and Inhibition of 1-Deoxy-d-Xylulose 5-Phosphate Reductoisomerase: A Promising Drug Target in Acinetobacter baumannii and Klebsiella pneumoniae.

Authors:  Haley S Ball; Misgina B Girma; Mosufa Zainab; Iswarduth Soojhawon; Robin D Couch; Schroeder M Noble
Journal:  ACS Infect Dis       Date:  2021-10-21       Impact factor: 5.578

3.  Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients.

Authors:  Chan-Yu Lin; Gareth W Roberts; Ann Kift-Morgan; Kieron L Donovan; Nicholas Topley; Matthias Eberl
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

4.  Resistance of Francisella novicida to fosmidomycin associated with mutations in the glycerol-3-phosphate transporter.

Authors:  Ryan S Mackie; Elizabeth S McKenney; Monique L van Hoek
Journal:  Front Microbiol       Date:  2012-08-09       Impact factor: 5.640

Review 5.  Pathogen-Specific Immune Fingerprints during Acute Infection: The Diagnostic Potential of Human γδ T-Cells.

Authors:  Matthias Eberl; Ida M Friberg; Anna Rita Liuzzi; Matt P Morgan; Nicholas Topley
Journal:  Front Immunol       Date:  2014-11-13       Impact factor: 7.561

6.  Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers.

Authors:  Jürgen Brem; Sander S van Berkel; David Zollman; Sook Y Lee; Opher Gileadi; Peter J McHugh; Timothy R Walsh; Michael A McDonough; Christopher J Schofield
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

7.  Fosmidomycin biosynthesis diverges from related phosphonate natural products.

Authors:  Elizabeth I Parkinson; Annette Erb; Andrew C Eliot; Kou-San Ju; William W Metcalf
Journal:  Nat Chem Biol       Date:  2019-08-26       Impact factor: 15.040

8.  Mutations in Escherichia coli aceE and ribB genes allow survival of strains defective in the first step of the isoprenoid biosynthesis pathway.

Authors:  Jordi Perez-Gil; Eva Maria Uros; Susanna Sauret-Güeto; L Maria Lois; James Kirby; Minobu Nishimoto; Edward E K Baidoo; Jay D Keasling; Albert Boronat; Manuel Rodriguez-Concepcion
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

9.  Unconventional Human T Cells Accumulate at the Site of Infection in Response to Microbial Ligands and Induce Local Tissue Remodeling.

Authors:  Anna Rita Liuzzi; Ann Kift-Morgan; Melisa Lopez-Anton; Ida M Friberg; Jingjing Zhang; Amy C Brook; Gareth W Roberts; Kieron L Donovan; Chantal S Colmont; Mark A Toleman; Timothy Bowen; David W Johnson; Nicholas Topley; Bernhard Moser; Donald J Fraser; Matthias Eberl
Journal:  J Immunol       Date:  2016-08-15       Impact factor: 5.422

10.  Fosmidomycin, an inhibitor of isoprenoid synthesis, induces persistence in Chlamydia by inhibiting peptidoglycan assembly.

Authors:  Jessica A Slade; Mary Brockett; Raghuveer Singh; George W Liechti; Anthony T Maurelli
Journal:  PLoS Pathog       Date:  2019-10-17       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.